Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)
China · Delayed Price · Currency is CNY 10.88
+0.24 (2.26%)
May 12, 2026, 3:04 PM CST
Xiangxue Pharmaceutical Market Cap
Xiangxue Pharmaceutical has a market cap or net worth of 7.19 billion as of May 12, 2026. Its market cap has increased by 109.23% in one year.
Market Cap
7.19B
Enterprise Value
8.87B
Revenue
1.53B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.88
Market Cap Chart
Since December 15, 2010, Xiangxue Pharmaceutical's market cap has increased from 4.81B to 7.19B, an increase of 49.60%. That is a compound annual growth rate of 2.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 7.04B | 16.92% |
| Dec 31, 2025 | 6.02B | -6.86% |
| Dec 31, 2024 | 6.46B | 89.71% |
| Dec 29, 2023 | 3.41B | -14.02% |
| Dec 30, 2022 | 3.96B | -24.79% |
| Dec 31, 2021 | 5.27B | -9.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 7.69B |
| Chengdu Kanghua Biological Products | 7.55B |
| Suzhou Fengbei Biotech Stock | 7.28B |
| Jiangsu Aidea Pharmaceutical Group | 7.23B |
| Shanghai OPM Biosciences | 7.23B |
| Wuhan Keqian Biology Co.,Ltd | 6.90B |
| Anhui Huaheng Biotechnology | 6.84B |
| Innovita Biological Technology | 6.83B |